Number Т. 16, №3 (63)

Keyword :   EGFR tyrosine kinase inhibitors (EGFR-TKIs)

Systemic treatment of locally advanced and metastatic EGFR-mutated NSCLC. What’s new?
Т. 16, №2 (62)